HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Silvia Requena Selected Research
Silvia Requena Research Topics
Disease
2
Hepatitis C
01/2019 - 01/2017
2
Chronic Hepatitis C
10/2018 - 01/2017
2
HIV Infections (HIV Infection)
10/2018 - 05/2018
1
Atherosclerosis
08/2022
1
Inflammation (Inflammations)
08/2022
1
Pneumonia (Pneumonitis)
01/2021
1
COVID-19
01/2021
1
Viremia
11/2019
1
Fibrosis (Cirrhosis)
01/2019
1
Liver Cirrhosis (Hepatic Cirrhosis)
10/2018
1
Disease Progression
05/2018
1
Infections
01/2017
1
Hemolytic Anemia
01/2017
Drug/Important Bio-Agent (IBA)
3
Antiviral Agents (Antivirals)
IBA
01/2019 - 01/2017
1
Messenger RNA (mRNA)
IBA
08/2022
1
Cytoplasmic and Nuclear Receptors (Nuclear Receptors)
IBA
08/2022
1
oxidized low density lipoprotein
IBA
08/2022
1
Tissue Inhibitor of Metalloproteinase-2
IBA
01/2021
1
Interleukin-17 (Interleukin 17)
IBA
01/2021
1
Cytokines
IBA
01/2021
1
Interleukin-10 (Interleukin 10)
IBA
01/2021
1
MicroRNAs (MicroRNA)
IBA
01/2021
1
Blood Proteins (Serum Proteins)
IBA
01/2021
1
Vaccines
IBA
05/2018
1
Interferons
IBA
01/2017
1
Raltegravir Potassium
FDA Link
01/2017
1
Ribavirin (Virazole)
FDA Link
Generic
01/2017
1
Integrases
IBA
01/2017
1
dolutegravir
IBA
01/2017
Therapy/Procedure
3
Therapeutics
11/2019 - 01/2017